Below is a list of funding opportunities that may be relevant for thoracic cancer research, including basic scientific research. Please read the funding guidelines to determine if your research proposal is eligible and that you meet other eligibility requirements.
- Early non small cell lung cancer
- Advanced non small cell lung cancer
- Small cell lung cancer/mesothelioma
- Supportive and palliative care
- Translational research
TOGA endorsement offers the following benefits:
- Use of TOGA logo or TOGA acknowledgment on all applications, presentations and publications
- Membership mailouts to assist with recruitment
- Listing of trial on the TOGA website
- Updates presented at Scientific Committee or other TOGA meetings (time permitting)
Further information is available in the TOGA Endorsement Policy.
If you know of additional funding opportunities that we can list, please contact firstname.lastname@example.org
|Grant Name||Research funded||Grant open date||Close date||Max funding||Duration||Application requirements|
|NHMRC Clinical Trials and Cohort Studies Grants||Clinical trials and cohort studies||29 June 2022||Min data 27 July 2022|
Full application24 August 2022
|Based on assessment of the requested budget.||1-5 years||Sapphire|
|Priority-driven Collaborative Cancer Research Scheme (PdCCRS)||Standard grants|
Early Career Researcher grants
(Lung cancer is a priority area)
|9 March 2022||31 August 2022 (17:00 AEST)||$200,000/year||1-3 years||NHMRC Clinical trials and cohort application
PdCCRS Questions application forms
|MRFF Clinical Trials Activity Initiative - 2022 International Clinical Trial Collaborations Grant Opportunity||Supports Australian medical research and medical innovation projects that promote Australian involvement in international collaborative investigator-initiated clinical trials|
research through the establishment and co-ordination of clinical trial site/s in Australia, for an internationally-led trial. An Australian-led trial inviting international site participation can also fund coordination of those international trial sites through this grant funding.
The clinical trial should not have commenced recruitment at the Australian trial
|30 March 2022||Min data 8 Feb 2023 (17:00 ACT time)|
Full application due 22 February 2023 (17:00 ACT time)
|$3 million||5 years||Application form
Where applicants are proposing to lead an international collaborative clinical trial, MRFF funding is available to support overarching coordination of trial sites both in Australia and overseas and to operate one or more clinical trial sites in Australia. Grant cannot support conduct at international clinical trial sites. (The international counterpart will need to find this funding)
Alternatively, where applicants are proposing to contribute to
clinical trials initiated by the international partners, MRFF funding is available to coordinate Australian
involvement and to conduct one or more clinical trial sites in Australia.